Studies of IgG-Class Anticardiolipin Antibodies in Myasthenia Gravis

References

• Vincent A. Immunology of acetylcholine receptors in relation to myasthenia gravis. Physiol Rev 1980; 60: 756–824
   PubMed Web of Science ®Google Scholar
• Thorlacius S, Aarlin JA, Risy T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis: autoimmune diseases and their relation to thymectomy. Acta Neurol. Scand 1989; 80: 290–295
   PubMed Web of Science ®Google Scholar
• van der Geld H., Feltkamp TEW, van Loghcm J J, Ooster-Huis HJGH, Biemond A. Multiple antibody production in myasthenia gravis. Lancet 1963; 2: 373–375
   PubMedGoogle Scholar
• Gershwin ME, Glinski W, Bender AN, Ringel SP, Steinberg AD, Engel WK. Antibodies to nucleic acids in myasthenia gravis. Int Arch Allergy Appl Immunol 1976; 51: 245–252
   PubMedGoogle Scholar
• Sagar HJ, Gelsthorpe K, Milford-Ward A, Davies-Joncs GAB. Clinical and immunological association in myasthenia gravis, part 1 (Autoantibodies). J. Neurol Neurosurg Psychial 1980; 43: 967–970
   PubMedGoogle Scholar
• McNeil HP, Chesterman CN, Krilis SA. Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 1991; 49: 193–280
   PubMed Web of Science ®Google Scholar
• Asherson RA, Derkson RH, Harris EN, Gharavi AE, Krauss T, Hughes GRV. Chorea in systemic lupus erythematosus and “lupus-like” disease : Association with antiphospholipid antibodies. Semin Arthritis Rheum 1987; 16: 253–259
   PubMedGoogle Scholar
• Lockshin MD, Qamar T, Druzin ML, Goei S. Antibody to cardiolipin, lupus anticoagulant and fetal death. J Rheumatol 1987; 14: 259–262
   PubMed Web of Science ®Google Scholar
• Harris EN, Gharavi AE, Boey ML, Patcl BM, Mackworth-Young CG, Loizou S, Hughes GRV. Anticardiolipin antibodies : detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211–1214
   PubMed Web of Science ®Google Scholar
• Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue G, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders : Association with anticardiolipin antibody. Br J Haematol 1985; 59: 227–230
   PubMed Web of Science ®Google Scholar
• Harris EN. Syndrome of the Black Swan. Rr J Rheumatol 1987; 26: 324–326
   PubMedGoogle Scholar
• Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHW, Machin SJ, Barquinero J. The “Primary” antiphospholipid syndrome : major clinical and serological features. Medicine 1989; 68: 366–374
   PubMed Web of Science ®Google Scholar
• Harris EN, Chan JKH, Asherson RA, Abcr VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia : predictive value of the anti-cardiolipin test. Arch Intern Med 1986; 146: 2153–2159
   PubMedGoogle Scholar
• Loizou S, Byron MA, Englert HJ, David J, Hughes GRV, Walport MS. Association of quantitative anti-cardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q.IMed 1988; 68: 525–531
   PubMedGoogle Scholar
• Colaco BC, Scadding G, Lockhart S. Anti-cardiolipin antibodies in neurological disorders: cross-reaction with anti-single stranded DNA activity. Clin Exp Immunol 1987; 68: 313–319
   PubMedGoogle Scholar
• Rombos A, Evangelopoulou-Katsiri E, Levantakou A, Voumrourakis K, Triantafyllou N, Papageorigiou C. Serum IgG and IgM anticardiolipin antibodies in neurological diseases. Ada neurol Scand 1990; 81: 243–245
   PubMed Web of Science ®Google Scholar
• Perlo VP, Poskanzer DC, Schwab RS, Viets HR, Osscrman KE, Genkis G. Myasthenia gravis: evaluation of treatment of 1355 patients. Neurology 1966; 16: 431–439
   PubMed Web of Science ®Google Scholar
• Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215–222
   PubMed Web of Science ®Google Scholar
• Morel E, Raimond F, Goulon Goeau C., Berrih S, Vcrnet der Garabcdian B, Harb J, Bach JF. Le dosage des anticorps antirccepteurs dc ('acetylcholine dans la myasthenic Etude de 329 cas. Presse Med 1982; 11: 1849–1854
   Google Scholar
• Lindström J. An assay for antibodies to human acetylcholine receptors in serum from patients with myasthenia gravis. Clin Immunol Immunopathol 1977; 7: 36–43
   PubMedGoogle Scholar
• Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies : isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1–6
   PubMed Web of Science ®Google Scholar
• Koike T, Sucshi M, Funaki H, Tomioka H, Yoshida S. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193–199
   PubMed Web of Science ®Google Scholar
• Loizou S, Mc Crea JD., Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation results. Clin Exp Immunol 1985; 62: 738–745
   PubMed Web of Science ®Google Scholar
• Tincani A, McRoni PL, Brucato A, Zanussi C, Allegro F, Mantclli P. Antiphospholipid and anti-mitochondrial type M5 antibodies in systemic lupus erythematosus. Clin Exp Immunol 1985; 3: 321–326
   Google Scholar
• Mc Neil HP., Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation : β2 glycoprotein 1 (apolipoprotein H). PNAS 1990; 87: 4120–4126
   PubMedGoogle Scholar
• Galli M, Comfurius P, Maassen C, Hemker HC, DeBacts MH, van Breda-Vriesman PJC. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544–1547
   PubMed Web of Science ®Google Scholar
• Chamley LW, McKay EJ, Pattison NS. Cofactor dependent and cofactor independent anticardiolipin antibodies. ThromhRes 1991; 61: 291–299
   PubMedGoogle Scholar
• Lockshin MD, Qamar T, Levy RA, Best MP. IgG but not IgM antiphospholipid antibody binding is temperature dependent. J Clin Immunol 1988; 8: 188–192
   PubMedGoogle Scholar
• Loizou S, Mackworth-Young CG, Conner C, Walport MJ. Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus erythematosus. Clin Exp Immunol 1990; 80: 171–176
   PubMedGoogle Scholar
• Harris EN, Gharavi AE, Wasley GD, Hughes GRV. Use of enzyme-linked immunosorbscnt assay and of inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis or autoimmune disorders. J Infect Dis 1988; 1: 23–31
   Google Scholar
• Koike T, Tomioka M, Kumagai A. Antibodies crossreactive with DNA and cardiolipin in patients with SLE. Clin Exp Immunol 1982; 50: 298–302
   PubMed Web of Science ®Google Scholar
• Harris EN, Gharavi AE, Loizou S, Derue G, Chan JK, Patel BM. Crossreactivity of antiphospholipid antibodies. J Clin Lah Immunol 1985; 16: 1–6
   PubMedGoogle Scholar
• Harris EN, Gharavi AE, Tincani A, Chan JKH, Englert H, Mantelli P. Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol; 1985; 17: 155–162
   PubMedGoogle Scholar
• Castelman B. The pathology of the thymus gland in myasthenia gravis. Ann NY Acad Sci 1966; 135: 496–503
   PubMedGoogle Scholar
• Genkins D, Kornfeld P, Papatestas AE, Bender AN, Matta RJ. Clinical experience in more than 2000 patients with myasthenia gravis. Ann N.YAcadSci 1987; 505: 500–513
   PubMedGoogle Scholar
• Thomas JA, Willcox HNA, Newson-Davis J. Immunohisto-logical studies of the thymus in myasthenia gravis : correlation with clinical state and thymocyte culture responses. J Neuwimmunol 1982; 3: 319–335
   PubMedGoogle Scholar
• Kao I, Drachman DB. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 1977; 195: 74–75
   PubMed Web of Science ®Google Scholar
• Vincent A, Thomas HC, Scadding GK, Newson-Davis J. In vitro synthesis of anti-acetylcholine receptor antibody by thymic lymphocytes in myasthenia gravis. Lancet 1978; i: 305–307
   Google Scholar